Formulation of solid dispersion to improve dissolution and oral bioavailability of poorly soluble dexibuprofen

References

• Ahsan MN, Verma PRP. 2018. Enhancement of in vitro dissolution and pharmacodynamic potential of olanzapine using solid SNEDDS. J Pharm Investig. 48:269–278.
   Google Scholar
• Balakrishnan P, Lee BJ, Oh DH, Kim JO, Hong MJ, Jee JP, Kim JA, Yoo BK, Woo JS, Yong CS, et al. 2009. Enhanced oral bioavailability of dexibuprofen by a novel solid Self-emulsifying drug delivery system (SEDDS). Eur J Pharm Biopharm. 72:539–545.
   PubMed Web of Science ®Google Scholar
• Berben P, Brouwers J, Augustijns P. 2018. Assessment of passive intestinal permeability using an artificial membrane insert system. J Pharm Sci. 107:250–256.
   PubMed Web of Science ®Google Scholar
• Bondan EF, Viebig LB, Dossa PD, Martins MFM, Casati MZ. 2017. Decreased GFAP expression in astrocytes of rats with experimentally induced rheumatoid arthritis and periodontitis and treated with resveratrol, curcumin or ibuprofen. J Comp Pathol. 156:139.
   Google Scholar
• Burki IK, Khan MK, Khan BA, Uzair B, Braga VA, Jamil QA. 2020. Formulation development, characterization, and evaluation of a novel dexibuprofen-capsaicin skin emulgel with improved in vivo anti-inflammatory and analgesic effects. AAPS PharmSciTech. 21:211.
   PubMed Web of Science ®Google Scholar
• Choi JS, Byeon JC, Park JS. 2019a. Naftopidil-fumaric acid interaction in a solid dispersion system: improving the dissolution rate and oral absorption of naftopidil in rats. Mater Sci Eng C Mater Biol Appl. 95:264–274.
   PubMed Web of Science ®Google Scholar
• Choi JS, Lee SE, Jang WS, Byeon JC, Park JS. 2017. Tadalafil solid dispersion formulations based on PVP/VA S-630: improving oral bioavailability in rats. Eur J Pharm Sci. 106:152–158.
   PubMed Web of Science ®Google Scholar
• Choi JS, Lee SE, Jang WS, Byeon JC, Park JS. 2018. Solid dispersion of dutasteride using the solvent evaporation method: approaches to improve dissolution rate and oral bioavailability in rats. Mater Sci Eng C Mater Biol Appl. 90:387–396.
   PubMed Web of Science ®Google Scholar
• Choi JS, Park JW, Park JS. 2019b. Design of Coenzyme Q10 solid dispersion for improved solubilization and stability. Int J Pharm. 572:118832.
   PubMedGoogle Scholar
• Choi Y, Min KA, Kim CK. 2019c. Development and evaluation of dexibuprofen formulation with fast onset and prolonged effect. Drug Dev Ind Pharm. 45:895–904.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 13:123–133.
   PubMed Web of Science ®Google Scholar
• Ding Z, Wang L, Xing Y, Zhao Y, Wang Z, Han J. 2019. Enhanced oral bioavailability of celecoxib nanocrystalline solid dispersion based on wet media milling technique: Formulation, optimization and in vitro/in vivo evaluation. Pharmaceutics. 11:328.
   Web of Science ®Google Scholar
• Gordo AC, Walker C, Armada B, Zhou D. 2017. Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial. J Int Med Res. 45:59–74.
   PubMed Web of Science ®Google Scholar
• Henriques J, Moreira J, Doktorovová S. 2021. QbD approach to downstream processing of spray-dried amorphous solid dispersions – a case study. Pharm Dev Technol.
   PubMed Web of Science ®Google Scholar
• Ho KY, Gwee KA, Cheng YK, Yoon KH, Hee HT, Omar AR. 2018. Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice. J Pain Res. 11:1937–1948.
   PubMed Web of Science ®Google Scholar
• ISO-10993-5. 2009. Biological evaluation of medical devices – part 5: tests for in vitro cytotoxicity.
   Google Scholar
• Kaehler ST, Phleps W, Hesse E. 2003. Dexibuprofen: pharmacology, therapeutic uses and safety. Inflammopharmacology. 11:371–383.
   PubMedGoogle Scholar
• Karashima M, Sano N, Yamamoto S, Arai Y, Yamamoto K, Amano N, Ikeda Y. 2017. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations. Eur J Pharm Biopharm. 115:65–72.
   PubMed Web of Science ®Google Scholar
• Karolewicz B, Gajda M, Górniak A, Owczarek A, Mucha I. 2017. Pluronic F127 as a suitable carrier for preparing the imatinib base solid dispersions and its potential in development of a modified release dosage forms. J Therm Anal Calorim. 130:383–390.
   Web of Science ®Google Scholar
• Kim NA, Oh HK, Lee JC, Choi YH, Jeong SH. 2021. Comparison of solubility enhancement by solid dispersion and micronized butein and its correlation with in vivo study. J Pharm Investig. 51:53–60.
   Web of Science ®Google Scholar
• Kwon J, Giri BR, Song ES, Bae J, Lee J, Kim DW. 2019. Spray-dried amorphous solid dispersions of atorvastatin calcium for improved supersaturation and oral bioavailability. Pharmaceutics. 11:461.
   PubMed Web of Science ®Google Scholar
• Lee HG, Park YS, Jeong JH, Kwon YB, Shin DH, Kim JY, Rhee YS, Park ES, Kim DW, Park CW, et al. 2019. Physicochemical properties and drug-release mechanisms of dual-release bilayer tablet containing mirabegron and fesoterodine fumarate. Drug Des Devel Ther. 13:2459–2474.
   PubMed Web of Science ®Google Scholar
• Liu X, Feng X, Williams RO, Zhang F. 2018. Characterization of amorphous solid dispersions. J Pharm Investig. 48:19–41.
   Google Scholar
• Luu TD, Lee BJ, Tran PHL, Tran TTD. 2019. Modified sprouted rice for modulation of curcumin crystallinity and dissolution enhancement by solid dispersion. J Pharm Investig. 49:127–134.
   Google Scholar
• Mehenni L, Lahiani-Skiba M, Ladam G, Hallouard F, Skiba M. 2018. Preparation and characterization of spherical amorphous solid dispersion with amphotericin B. Pharmaceutics. 10:235.
   Web of Science ®Google Scholar
• Newa M, Bhandari KH, Lee DX, Sung JH, Kim JA, Yoo BK, Woo JS, Choi HG, Yong CS. 2008a. Enhanced dissolution of ibuprofen using solid dispersion with polyethylene glycol 20000. Drug Dev Ind Pharm. 34:1013–1021.
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Oh DH, Kim YR, Sung JH, Kim JO, Woo JS, Choi HG, Yong CS. 2008b. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Arch Pharm Res. 31:1497–1507.
   PubMed Web of Science ®Google Scholar
• Oh S, Shin WS, Kim HT. 2016. Effects of pH, dissolved organic matter, and salinity on ibuprofen sorption on sediment. Environ Sci Pollut Res Int. 23:22882–22889.
   PubMed Web of Science ®Google Scholar
• Okunlola A, Ghomorai T. 2018. Development of ibuprofen microspheres using acetylated plantain starches as polymer for sustained release. J Pharm Investig. 48:551–564.
   Google Scholar
• Patel TB, Patel LD, Patel TB, et al. 2010. Formulation and characterization of solid dispersions containing glibenclamide. Int J Pharm Pharm Sci. 2:138–141.
   Google Scholar
• Potthast H, Dressman JB, Junginger HE, Midha KK, Oeser H, Shah VP, Vogelpoel H, Barends DM. 2005. Biowaiver monographs for immediate release solid oral dosage forms: Ibuprofen. J Pharm Sci. 94:2121–2131.
   PubMed Web of Science ®Google Scholar
• Rinaki E, Dokoumetzidis A, Valsami G, Macheras P. 2004. Identification of biowaivers among class II drugs: theoretical justification and practical examples. Pharm Res. 21:1567–1572.
   PubMed Web of Science ®Google Scholar
• Rivera-Leyva JC, García-Flores M, Valladares-Méndez A, Orozco-Castellanos LM, Martínez-Alfaro M. 2012. Comparative studies on the dissolution profiles of oral ibuprofen suspension and commercial tablets using biopharmaceutical classification system criteria. Indian J Pharm Sci. 74:312–318.
   PubMed Web of Science ®Google Scholar
• Singh D, Bedi N, Tiwary AK. 2018. Enhancing solubility of poorly aqueous soluble drugs: critical appraisal of techniques. J Pharm Investig. 48:509–526.
   Google Scholar
• Soliman MAN, Ibrahim HK, Nour SK. 2021. Diacerein solid dispersion loaded tablets for minimization of drug adverse effects: statistical design, formulation, in vitro, and in vivo evaluation. Pharm Dev Technol.
   PubMed Web of Science ®Google Scholar
• Stoyanova K, Vinarov Z, Tcholakova S. 2016. Improving ibuprofen solubility by surfactant-facilitated self-assembly into mixed micelles. J Drug Deliv Sci Technol. 36:208–215.
   Web of Science ®Google Scholar
• Tran P, Pyo YC, Kim DH, Lee SE, Kim JK, Park JS. 2019. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs. Pharmaceutics. 11:132.
   PubMed Web of Science ®Google Scholar
• Tsume Y, Langguth P, Garcia-Arieta A, Amidon GL. 2012. In silico prediction of drug dissolution and absorption with variation in intestinal pH for BCS class II weak acid drugs: ibuprofen and ketoprofen. Biopharm Drug Dispos. 33:366–377.
   PubMed Web of Science ®Google Scholar
• Ullah N, Khan S, Ahmed S, Govender T, Faidah HS, Matas M. d, Shahid M, Usman Minhas M, Sohail M, Khurram M, et al. 2018. Dexibuprofen nanocrystals with improved therapeutic performance: fabrication, characterization, in silico modeling, and in vivo evaluation. IJN. 13:1677–1692.
   Google Scholar
• Wen T, Niu B, Wu Q, Zhou Y, Pan X, Quan G, Wu C. 2019. Fenofibrate solid dispersion processed by hot-melt extrusion: elevated bioavailability and its cell transport mechanism. Curr Drug Deliv. 16:538–547.
   PubMed Web of Science ®Google Scholar
• Yan YD, Sung JH, Kim KK, Kim DW, Kim JO, Lee BJ, Yong CS, Choi HG. 2012. Novel valsartan-loaded solid dispersion with enhanced bioavailability and no crystalline changes. Int J Pharm. 422:202–210.
   PubMed Web of Science ®Google Scholar